nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—ABCB1—epilepsy syndrome	0.133	1	CbGaD
Candesartan—UGT1A3—Lamotrigine—epilepsy syndrome	0.118	0.196	CbGbCtD
Candesartan—UGT1A3—Valproic Acid—epilepsy syndrome	0.0608	0.101	CbGbCtD
Candesartan—CYP2C8—Trimethadione—epilepsy syndrome	0.0276	0.0457	CbGbCtD
Candesartan—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0259	0.043	CbGbCtD
Candesartan—PTGS1—Diazepam—epilepsy syndrome	0.0245	0.0406	CbGbCtD
Candesartan—ABCB1—Levetiracetam—epilepsy syndrome	0.022	0.0364	CbGbCtD
Candesartan—PTGS1—Valproic Acid—epilepsy syndrome	0.0193	0.032	CbGbCtD
Candesartan—CYP2C9—Trimethadione—epilepsy syndrome	0.0192	0.0319	CbGbCtD
Candesartan—CYP2C8—Carbamazepine—epilepsy syndrome	0.0186	0.0309	CbGbCtD
Candesartan—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0181	0.03	CbGbCtD
Candesartan—CYP2C8—Primidone—epilepsy syndrome	0.0174	0.0288	CbGbCtD
Candesartan—CYP2C8—Phenytoin—epilepsy syndrome	0.0167	0.0277	CbGbCtD
Candesartan—CYP2C8—Propofol—epilepsy syndrome	0.0156	0.0258	CbGbCtD
Candesartan—ABCB1—Clobazam—epilepsy syndrome	0.0152	0.0252	CbGbCtD
Candesartan—CYP2C8—Phenobarbital—epilepsy syndrome	0.0149	0.0247	CbGbCtD
Candesartan—ABCB1—Lamotrigine—epilepsy syndrome	0.0147	0.0243	CbGbCtD
Candesartan—CYP2C8—Diazepam—epilepsy syndrome	0.0141	0.0234	CbGbCtD
Candesartan—CYP2C9—Carbamazepine—epilepsy syndrome	0.013	0.0215	CbGbCtD
Candesartan—ABCB1—Carbamazepine—epilepsy syndrome	0.0126	0.0209	CbGbCtD
Candesartan—CYP2C9—Primidone—epilepsy syndrome	0.0121	0.0201	CbGbCtD
Candesartan—CYP2C9—Phenytoin—epilepsy syndrome	0.0117	0.0193	CbGbCtD
Candesartan—ABCB1—Phenytoin—epilepsy syndrome	0.0113	0.0188	CbGbCtD
Candesartan—CYP2C8—Valproic Acid—epilepsy syndrome	0.0111	0.0185	CbGbCtD
Candesartan—CYP2C9—Propofol—epilepsy syndrome	0.0109	0.018	CbGbCtD
Candesartan—CYP2C9—Phenobarbital—epilepsy syndrome	0.0104	0.0172	CbGbCtD
Candesartan—ABCB1—Phenobarbital—epilepsy syndrome	0.0101	0.0167	CbGbCtD
Candesartan—ABCB1—Midazolam—epilepsy syndrome	0.00995	0.0165	CbGbCtD
Candesartan—CYP2C9—Diazepam—epilepsy syndrome	0.00985	0.0163	CbGbCtD
Candesartan—ABCB1—Diazepam—epilepsy syndrome	0.00956	0.0158	CbGbCtD
Candesartan—CYP2C9—Valproic Acid—epilepsy syndrome	0.00777	0.0129	CbGbCtD
Candesartan—Irbesartan—JUN—epilepsy syndrome	0.000847	0.208	CrCbGaD
Candesartan—Pranlukast—ABCC2—epilepsy syndrome	0.000522	0.128	CrCbGaD
Candesartan—Pranlukast—TNF—epilepsy syndrome	0.000476	0.117	CrCbGaD
Candesartan—Olmesartan—ABCC2—epilepsy syndrome	0.000415	0.102	CrCbGaD
Candesartan—Telmisartan—ABCC2—epilepsy syndrome	0.0004	0.0983	CrCbGaD
Candesartan—Telmisartan—ABCG2—epilepsy syndrome	0.000354	0.0869	CrCbGaD
Candesartan—Telmisartan—CYP2C19—epilepsy syndrome	0.000278	0.0683	CrCbGaD
Candesartan—Irbesartan—CYP2D6—epilepsy syndrome	0.000166	0.0408	CrCbGaD
Candesartan—Valsartan—ALB—epilepsy syndrome	0.000164	0.0403	CrCbGaD
Candesartan—Telmisartan—ABCB1—epilepsy syndrome	0.000147	0.0362	CrCbGaD
Candesartan—Losartan—CYP2C19—epilepsy syndrome	0.000144	0.0355	CrCbGaD
Candesartan—Vomiting—Midazolam—epilepsy syndrome	0.000115	0.000623	CcSEcCtD
Candesartan—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000115	0.000623	CcSEcCtD
Candesartan—Asthenia—Felbamate—epilepsy syndrome	0.000115	0.000622	CcSEcCtD
Candesartan—Chest pain—Valproic Acid—epilepsy syndrome	0.000115	0.000621	CcSEcCtD
Candesartan—Arthralgia—Valproic Acid—epilepsy syndrome	0.000115	0.000621	CcSEcCtD
Candesartan—Myalgia—Valproic Acid—epilepsy syndrome	0.000115	0.000621	CcSEcCtD
Candesartan—Haematuria—Topiramate—epilepsy syndrome	0.000115	0.000621	CcSEcCtD
Candesartan—Anxiety—Valproic Acid—epilepsy syndrome	0.000115	0.000619	CcSEcCtD
Candesartan—Rash—Midazolam—epilepsy syndrome	0.000114	0.000618	CcSEcCtD
Candesartan—Dizziness—Fosphenytoin—epilepsy syndrome	0.000114	0.000617	CcSEcCtD
Candesartan—Dermatitis—Midazolam—epilepsy syndrome	0.000114	0.000617	CcSEcCtD
Candesartan—Urticaria—Carbamazepine—epilepsy syndrome	0.000114	0.000616	CcSEcCtD
Candesartan—Vomiting—Levetiracetam—epilepsy syndrome	0.000114	0.000615	CcSEcCtD
Candesartan—Epistaxis—Topiramate—epilepsy syndrome	0.000114	0.000614	CcSEcCtD
Candesartan—Headache—Midazolam—epilepsy syndrome	0.000114	0.000614	CcSEcCtD
Candesartan—Pruritus—Felbamate—epilepsy syndrome	0.000114	0.000613	CcSEcCtD
Candesartan—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000113	0.000613	CcSEcCtD
Candesartan—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000113	0.000613	CcSEcCtD
Candesartan—Diarrhoea—Diazepam—epilepsy syndrome	0.000113	0.000613	CcSEcCtD
Candesartan—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000113	0.000613	CcSEcCtD
Candesartan—Sinusitis—Topiramate—epilepsy syndrome	0.000113	0.000611	CcSEcCtD
Candesartan—Rash—Levetiracetam—epilepsy syndrome	0.000113	0.00061	CcSEcCtD
Candesartan—Anaemia—Pregabalin—epilepsy syndrome	0.000113	0.00061	CcSEcCtD
Candesartan—Dermatitis—Levetiracetam—epilepsy syndrome	0.000113	0.000609	CcSEcCtD
Candesartan—Asthenia—Zonisamide—epilepsy syndrome	0.000113	0.000609	CcSEcCtD
Candesartan—Mental disorder—Gabapentin—epilepsy syndrome	0.000113	0.000609	CcSEcCtD
Candesartan—Agranulocytosis—Topiramate—epilepsy syndrome	0.000113	0.000608	CcSEcCtD
Candesartan—Headache—Levetiracetam—epilepsy syndrome	0.000112	0.000606	CcSEcCtD
Candesartan—Malnutrition—Gabapentin—epilepsy syndrome	0.000112	0.000605	CcSEcCtD
Candesartan—Angioedema—Pregabalin—epilepsy syndrome	0.000112	0.000603	CcSEcCtD
Candesartan—Dizziness—Vigabatrin—epilepsy syndrome	0.000111	0.000602	CcSEcCtD
Candesartan—Pruritus—Zonisamide—epilepsy syndrome	0.000111	0.0006	CcSEcCtD
Candesartan—Urticaria—Lamotrigine—epilepsy syndrome	0.00011	0.000595	CcSEcCtD
Candesartan—Nausea—Propofol—epilepsy syndrome	0.00011	0.000595	CcSEcCtD
Candesartan—Vomiting—Fosphenytoin—epilepsy syndrome	0.00011	0.000594	CcSEcCtD
Candesartan—Diarrhoea—Felbamate—epilepsy syndrome	0.00011	0.000593	CcSEcCtD
Candesartan—Vertigo—Pregabalin—epilepsy syndrome	0.00011	0.000593	CcSEcCtD
Candesartan—Abdominal pain—Lamotrigine—epilepsy syndrome	0.00011	0.000592	CcSEcCtD
Candesartan—Body temperature increased—Lamotrigine—epilepsy syndrome	0.00011	0.000592	CcSEcCtD
Candesartan—Dizziness—Diazepam—epilepsy syndrome	0.00011	0.000592	CcSEcCtD
Candesartan—Leukopenia—Pregabalin—epilepsy syndrome	0.000109	0.000591	CcSEcCtD
Candesartan—Rash—Fosphenytoin—epilepsy syndrome	0.000109	0.000589	CcSEcCtD
Candesartan—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000109	0.000588	CcSEcCtD
Candesartan—Haemoglobin—Topiramate—epilepsy syndrome	0.000109	0.000588	CcSEcCtD
Candesartan—Asthenia—Clonazepam—epilepsy syndrome	0.000109	0.000587	CcSEcCtD
Candesartan—Rhinitis—Topiramate—epilepsy syndrome	0.000108	0.000586	CcSEcCtD
Candesartan—Back pain—Gabapentin—epilepsy syndrome	0.000108	0.000585	CcSEcCtD
Candesartan—Headache—Fosphenytoin—epilepsy syndrome	0.000108	0.000585	CcSEcCtD
Candesartan—Haemorrhage—Topiramate—epilepsy syndrome	0.000108	0.000585	CcSEcCtD
Candesartan—Hepatitis—Topiramate—epilepsy syndrome	0.000108	0.000585	CcSEcCtD
Candesartan—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000108	0.000583	CcSEcCtD
Candesartan—Palpitations—Pregabalin—epilepsy syndrome	0.000108	0.000583	CcSEcCtD
Candesartan—Asthenia—Phenytoin—epilepsy syndrome	0.000108	0.000583	CcSEcCtD
Candesartan—Nausea—Midazolam—epilepsy syndrome	0.000108	0.000582	CcSEcCtD
Candesartan—Tachycardia—Valproic Acid—epilepsy syndrome	0.000108	0.000581	CcSEcCtD
Candesartan—Diarrhoea—Zonisamide—epilepsy syndrome	0.000107	0.000581	CcSEcCtD
Candesartan—Pharyngitis—Topiramate—epilepsy syndrome	0.000107	0.00058	CcSEcCtD
Candesartan—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000107	0.00058	CcSEcCtD
Candesartan—Pruritus—Clonazepam—epilepsy syndrome	0.000107	0.000579	CcSEcCtD
Candesartan—Vomiting—Vigabatrin—epilepsy syndrome	0.000107	0.000579	CcSEcCtD
Candesartan—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000107	0.000577	CcSEcCtD
Candesartan—Oedema peripheral—Topiramate—epilepsy syndrome	0.000107	0.000576	CcSEcCtD
Candesartan—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000107	0.000576	CcSEcCtD
Candesartan—Cough—Pregabalin—epilepsy syndrome	0.000107	0.000576	CcSEcCtD
Candesartan—Pruritus—Phenytoin—epilepsy syndrome	0.000106	0.000575	CcSEcCtD
Candesartan—Nausea—Levetiracetam—epilepsy syndrome	0.000106	0.000575	CcSEcCtD
Candesartan—Rash—Vigabatrin—epilepsy syndrome	0.000106	0.000574	CcSEcCtD
Candesartan—Dizziness—Felbamate—epilepsy syndrome	0.000106	0.000573	CcSEcCtD
Candesartan—Dermatitis—Vigabatrin—epilepsy syndrome	0.000106	0.000573	CcSEcCtD
Candesartan—Urethral disorder—Topiramate—epilepsy syndrome	0.000106	0.000573	CcSEcCtD
Candesartan—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000106	0.000572	CcSEcCtD
Candesartan—Headache—Vigabatrin—epilepsy syndrome	0.000106	0.00057	CcSEcCtD
Candesartan—Hypertension—Pregabalin—epilepsy syndrome	0.000105	0.00057	CcSEcCtD
Candesartan—Vomiting—Diazepam—epilepsy syndrome	0.000105	0.00057	CcSEcCtD
Candesartan—Rash—Diazepam—epilepsy syndrome	0.000105	0.000565	CcSEcCtD
Candesartan—Dermatitis—Diazepam—epilepsy syndrome	0.000104	0.000564	CcSEcCtD
Candesartan—Arthralgia—Pregabalin—epilepsy syndrome	0.000104	0.000562	CcSEcCtD
Candesartan—Chest pain—Pregabalin—epilepsy syndrome	0.000104	0.000562	CcSEcCtD
Candesartan—Myalgia—Pregabalin—epilepsy syndrome	0.000104	0.000562	CcSEcCtD
Candesartan—Dizziness—Zonisamide—epilepsy syndrome	0.000104	0.000561	CcSEcCtD
Candesartan—Headache—Diazepam—epilepsy syndrome	0.000104	0.000561	CcSEcCtD
Candesartan—Anxiety—Pregabalin—epilepsy syndrome	0.000104	0.00056	CcSEcCtD
Candesartan—Diarrhoea—Clonazepam—epilepsy syndrome	0.000104	0.00056	CcSEcCtD
Candesartan—Anaemia—Gabapentin—epilepsy syndrome	0.000103	0.000559	CcSEcCtD
Candesartan—Hypotension—Valproic Acid—epilepsy syndrome	0.000103	0.000557	CcSEcCtD
Candesartan—Asthenia—Carbamazepine—epilepsy syndrome	0.000103	0.000556	CcSEcCtD
Candesartan—Diarrhoea—Phenytoin—epilepsy syndrome	0.000103	0.000556	CcSEcCtD
Candesartan—Nausea—Fosphenytoin—epilepsy syndrome	0.000103	0.000554	CcSEcCtD
Candesartan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000102	0.000553	CcSEcCtD
Candesartan—Angioedema—Gabapentin—epilepsy syndrome	0.000102	0.000553	CcSEcCtD
Candesartan—Vomiting—Felbamate—epilepsy syndrome	0.000102	0.000551	CcSEcCtD
Candesartan—Pruritus—Carbamazepine—epilepsy syndrome	0.000102	0.000549	CcSEcCtD
Candesartan—Rash—Felbamate—epilepsy syndrome	0.000101	0.000547	CcSEcCtD
Candesartan—Dermatitis—Felbamate—epilepsy syndrome	0.000101	0.000546	CcSEcCtD
Candesartan—Vertigo—Gabapentin—epilepsy syndrome	0.000101	0.000544	CcSEcCtD
Candesartan—Headache—Felbamate—epilepsy syndrome	0.000101	0.000543	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.0001	0.000543	CcSEcCtD
Candesartan—Leukopenia—Gabapentin—epilepsy syndrome	0.0001	0.000542	CcSEcCtD
Candesartan—Dizziness—Clonazepam—epilepsy syndrome	0.0001	0.000541	CcSEcCtD
Candesartan—Nausea—Vigabatrin—epilepsy syndrome	0.0001	0.00054	CcSEcCtD
Candesartan—Vomiting—Zonisamide—epilepsy syndrome	9.99e-05	0.00054	CcSEcCtD
Candesartan—Asthenia—Lamotrigine—epilepsy syndrome	9.95e-05	0.000538	CcSEcCtD
Candesartan—Dizziness—Phenytoin—epilepsy syndrome	9.94e-05	0.000537	CcSEcCtD
Candesartan—Rash—Zonisamide—epilepsy syndrome	9.9e-05	0.000535	CcSEcCtD
Candesartan—Paraesthesia—Valproic Acid—epilepsy syndrome	9.9e-05	0.000535	CcSEcCtD
Candesartan—Palpitations—Gabapentin—epilepsy syndrome	9.9e-05	0.000535	CcSEcCtD
Candesartan—Dermatitis—Zonisamide—epilepsy syndrome	9.9e-05	0.000535	CcSEcCtD
Candesartan—Dizziness—Oxcarbazepine—epilepsy syndrome	9.89e-05	0.000534	CcSEcCtD
Candesartan—Nausea—Diazepam—epilepsy syndrome	9.85e-05	0.000532	CcSEcCtD
Candesartan—Headache—Zonisamide—epilepsy syndrome	9.84e-05	0.000532	CcSEcCtD
Candesartan—Dyspnoea—Valproic Acid—epilepsy syndrome	9.83e-05	0.000531	CcSEcCtD
Candesartan—Diarrhoea—Carbamazepine—epilepsy syndrome	9.82e-05	0.000531	CcSEcCtD
Candesartan—Pruritus—Lamotrigine—epilepsy syndrome	9.82e-05	0.00053	CcSEcCtD
Candesartan—Somnolence—Valproic Acid—epilepsy syndrome	9.8e-05	0.000529	CcSEcCtD
Candesartan—Cough—Gabapentin—epilepsy syndrome	9.77e-05	0.000528	CcSEcCtD
Candesartan—Thrombocytopenia—Pregabalin—epilepsy syndrome	9.76e-05	0.000527	CcSEcCtD
Candesartan—Tachycardia—Pregabalin—epilepsy syndrome	9.73e-05	0.000525	CcSEcCtD
Candesartan—Dyspepsia—Valproic Acid—epilepsy syndrome	9.7e-05	0.000524	CcSEcCtD
Candesartan—Hypertension—Gabapentin—epilepsy syndrome	9.67e-05	0.000522	CcSEcCtD
Candesartan—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.63e-05	0.000521	CcSEcCtD
Candesartan—Vomiting—Clonazepam—epilepsy syndrome	9.63e-05	0.00052	CcSEcCtD
Candesartan—Vomiting—Phenytoin—epilepsy syndrome	9.56e-05	0.000517	CcSEcCtD
Candesartan—Rash—Clonazepam—epilepsy syndrome	9.55e-05	0.000516	CcSEcCtD
Candesartan—Dermatitis—Clonazepam—epilepsy syndrome	9.54e-05	0.000515	CcSEcCtD
Candesartan—Chest pain—Gabapentin—epilepsy syndrome	9.53e-05	0.000515	CcSEcCtD
Candesartan—Arthralgia—Gabapentin—epilepsy syndrome	9.53e-05	0.000515	CcSEcCtD
Candesartan—Myalgia—Gabapentin—epilepsy syndrome	9.53e-05	0.000515	CcSEcCtD
Candesartan—Nausea—Felbamate—epilepsy syndrome	9.53e-05	0.000515	CcSEcCtD
Candesartan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.52e-05	0.000514	CcSEcCtD
Candesartan—Vomiting—Oxcarbazepine—epilepsy syndrome	9.51e-05	0.000514	CcSEcCtD
Candesartan—Fatigue—Valproic Acid—epilepsy syndrome	9.5e-05	0.000513	CcSEcCtD
Candesartan—Anxiety—Gabapentin—epilepsy syndrome	9.5e-05	0.000513	CcSEcCtD
Candesartan—Dizziness—Carbamazepine—epilepsy syndrome	9.49e-05	0.000513	CcSEcCtD
Candesartan—Diarrhoea—Lamotrigine—epilepsy syndrome	9.49e-05	0.000513	CcSEcCtD
Candesartan—Headache—Clonazepam—epilepsy syndrome	9.48e-05	0.000512	CcSEcCtD
Candesartan—Rash—Phenytoin—epilepsy syndrome	9.48e-05	0.000512	CcSEcCtD
Candesartan—Mental disorder—Topiramate—epilepsy syndrome	9.48e-05	0.000512	CcSEcCtD
Candesartan—Dermatitis—Phenytoin—epilepsy syndrome	9.47e-05	0.000512	CcSEcCtD
Candesartan—Rash—Oxcarbazepine—epilepsy syndrome	9.43e-05	0.00051	CcSEcCtD
Candesartan—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.42e-05	0.000509	CcSEcCtD
Candesartan—Headache—Phenytoin—epilepsy syndrome	9.42e-05	0.000509	CcSEcCtD
Candesartan—Malnutrition—Topiramate—epilepsy syndrome	9.42e-05	0.000509	CcSEcCtD
Candesartan—Headache—Oxcarbazepine—epilepsy syndrome	9.37e-05	0.000506	CcSEcCtD
Candesartan—Nausea—Zonisamide—epilepsy syndrome	9.33e-05	0.000504	CcSEcCtD
Candesartan—Hypotension—Pregabalin—epilepsy syndrome	9.31e-05	0.000503	CcSEcCtD
Candesartan—Dizziness—Lamotrigine—epilepsy syndrome	9.17e-05	0.000496	CcSEcCtD
Candesartan—Vomiting—Carbamazepine—epilepsy syndrome	9.13e-05	0.000493	CcSEcCtD
Candesartan—Back pain—Topiramate—epilepsy syndrome	9.11e-05	0.000492	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	9.08e-05	0.000491	CcSEcCtD
Candesartan—Rash—Carbamazepine—epilepsy syndrome	9.05e-05	0.000489	CcSEcCtD
Candesartan—Dermatitis—Carbamazepine—epilepsy syndrome	9.04e-05	0.000489	CcSEcCtD
Candesartan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	9.01e-05	0.000487	CcSEcCtD
Candesartan—Nausea—Clonazepam—epilepsy syndrome	8.99e-05	0.000486	CcSEcCtD
Candesartan—Headache—Carbamazepine—epilepsy syndrome	8.99e-05	0.000486	CcSEcCtD
Candesartan—Paraesthesia—Pregabalin—epilepsy syndrome	8.95e-05	0.000483	CcSEcCtD
Candesartan—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.95e-05	0.000483	CcSEcCtD
Candesartan—Nausea—Phenytoin—epilepsy syndrome	8.93e-05	0.000483	CcSEcCtD
Candesartan—Tachycardia—Gabapentin—epilepsy syndrome	8.92e-05	0.000482	CcSEcCtD
Candesartan—Dyspnoea—Pregabalin—epilepsy syndrome	8.89e-05	0.00048	CcSEcCtD
Candesartan—Nausea—Oxcarbazepine—epilepsy syndrome	8.89e-05	0.00048	CcSEcCtD
Candesartan—Somnolence—Pregabalin—epilepsy syndrome	8.86e-05	0.000479	CcSEcCtD
Candesartan—Hyperhidrosis—Gabapentin—epilepsy syndrome	8.83e-05	0.000477	CcSEcCtD
Candesartan—Vomiting—Lamotrigine—epilepsy syndrome	8.82e-05	0.000477	CcSEcCtD
Candesartan—Urticaria—Valproic Acid—epilepsy syndrome	8.76e-05	0.000473	CcSEcCtD
Candesartan—Rash—Lamotrigine—epilepsy syndrome	8.75e-05	0.000473	CcSEcCtD
Candesartan—Dermatitis—Lamotrigine—epilepsy syndrome	8.74e-05	0.000472	CcSEcCtD
Candesartan—Abdominal pain—Valproic Acid—epilepsy syndrome	8.71e-05	0.000471	CcSEcCtD
Candesartan—Body temperature increased—Valproic Acid—epilepsy syndrome	8.71e-05	0.000471	CcSEcCtD
Candesartan—Anaemia—Topiramate—epilepsy syndrome	8.71e-05	0.00047	CcSEcCtD
Candesartan—Headache—Lamotrigine—epilepsy syndrome	8.69e-05	0.00047	CcSEcCtD
Candesartan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.6e-05	0.000465	CcSEcCtD
Candesartan—Fatigue—Pregabalin—epilepsy syndrome	8.59e-05	0.000464	CcSEcCtD
Candesartan—Hypotension—Gabapentin—epilepsy syndrome	8.54e-05	0.000461	CcSEcCtD
Candesartan—Nausea—Carbamazepine—epilepsy syndrome	8.53e-05	0.000461	CcSEcCtD
Candesartan—Vertigo—Topiramate—epilepsy syndrome	8.46e-05	0.000457	CcSEcCtD
Candesartan—Leukopenia—Topiramate—epilepsy syndrome	8.43e-05	0.000456	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	8.33e-05	0.00045	CcSEcCtD
Candesartan—Palpitations—Topiramate—epilepsy syndrome	8.33e-05	0.00045	CcSEcCtD
Candesartan—Nausea—Lamotrigine—epilepsy syndrome	8.24e-05	0.000445	CcSEcCtD
Candesartan—Cough—Topiramate—epilepsy syndrome	8.22e-05	0.000444	CcSEcCtD
Candesartan—Paraesthesia—Gabapentin—epilepsy syndrome	8.21e-05	0.000443	CcSEcCtD
Candesartan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	8.15e-05	0.00044	CcSEcCtD
Candesartan—Dyspnoea—Gabapentin—epilepsy syndrome	8.15e-05	0.00044	CcSEcCtD
Candesartan—Hypertension—Topiramate—epilepsy syndrome	8.13e-05	0.000439	CcSEcCtD
Candesartan—Somnolence—Gabapentin—epilepsy syndrome	8.12e-05	0.000439	CcSEcCtD
Candesartan—Dyspepsia—Gabapentin—epilepsy syndrome	8.04e-05	0.000435	CcSEcCtD
Candesartan—Myalgia—Topiramate—epilepsy syndrome	8.02e-05	0.000433	CcSEcCtD
Candesartan—Chest pain—Topiramate—epilepsy syndrome	8.02e-05	0.000433	CcSEcCtD
Candesartan—Arthralgia—Topiramate—epilepsy syndrome	8.02e-05	0.000433	CcSEcCtD
Candesartan—Losartan—ALB—epilepsy syndrome	8.01e-05	0.0197	CrCbGaD
Candesartan—Anxiety—Topiramate—epilepsy syndrome	7.99e-05	0.000432	CcSEcCtD
Candesartan—Urticaria—Pregabalin—epilepsy syndrome	7.92e-05	0.000428	CcSEcCtD
Candesartan—Asthenia—Valproic Acid—epilepsy syndrome	7.91e-05	0.000427	CcSEcCtD
Candesartan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.89e-05	0.000426	CcSEcCtD
Candesartan—Fatigue—Gabapentin—epilepsy syndrome	7.88e-05	0.000426	CcSEcCtD
Candesartan—Abdominal pain—Pregabalin—epilepsy syndrome	7.88e-05	0.000426	CcSEcCtD
Candesartan—Body temperature increased—Pregabalin—epilepsy syndrome	7.88e-05	0.000426	CcSEcCtD
Candesartan—Pruritus—Valproic Acid—epilepsy syndrome	7.8e-05	0.000421	CcSEcCtD
Candesartan—Losartan—ABCB1—epilepsy syndrome	7.65e-05	0.0188	CrCbGaD
Candesartan—Diarrhoea—Valproic Acid—epilepsy syndrome	7.54e-05	0.000407	CcSEcCtD
Candesartan—Thrombocytopenia—Topiramate—epilepsy syndrome	7.53e-05	0.000407	CcSEcCtD
Candesartan—Tachycardia—Topiramate—epilepsy syndrome	7.5e-05	0.000405	CcSEcCtD
Candesartan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.47e-05	0.000404	CcSEcCtD
Candesartan—Hyperhidrosis—Topiramate—epilepsy syndrome	7.43e-05	0.000402	CcSEcCtD
Candesartan—Dizziness—Valproic Acid—epilepsy syndrome	7.29e-05	0.000394	CcSEcCtD
Candesartan—Urticaria—Gabapentin—epilepsy syndrome	7.26e-05	0.000392	CcSEcCtD
Candesartan—Abdominal pain—Gabapentin—epilepsy syndrome	7.22e-05	0.00039	CcSEcCtD
Candesartan—Body temperature increased—Gabapentin—epilepsy syndrome	7.22e-05	0.00039	CcSEcCtD
Candesartan—Hypotension—Topiramate—epilepsy syndrome	7.18e-05	0.000388	CcSEcCtD
Candesartan—Asthenia—Pregabalin—epilepsy syndrome	7.15e-05	0.000386	CcSEcCtD
Candesartan—Pruritus—Pregabalin—epilepsy syndrome	7.05e-05	0.000381	CcSEcCtD
Candesartan—Vomiting—Valproic Acid—epilepsy syndrome	7.01e-05	0.000379	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	7.01e-05	0.000378	CcSEcCtD
Candesartan—Rash—Valproic Acid—epilepsy syndrome	6.95e-05	0.000376	CcSEcCtD
Candesartan—Dermatitis—Valproic Acid—epilepsy syndrome	6.94e-05	0.000375	CcSEcCtD
Candesartan—Headache—Valproic Acid—epilepsy syndrome	6.91e-05	0.000373	CcSEcCtD
Candesartan—Paraesthesia—Topiramate—epilepsy syndrome	6.9e-05	0.000373	CcSEcCtD
Candesartan—Dyspnoea—Topiramate—epilepsy syndrome	6.85e-05	0.00037	CcSEcCtD
Candesartan—Somnolence—Topiramate—epilepsy syndrome	6.84e-05	0.000369	CcSEcCtD
Candesartan—Diarrhoea—Pregabalin—epilepsy syndrome	6.82e-05	0.000368	CcSEcCtD
Candesartan—Dyspepsia—Topiramate—epilepsy syndrome	6.77e-05	0.000366	CcSEcCtD
Candesartan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.64e-05	0.000359	CcSEcCtD
Candesartan—Fatigue—Topiramate—epilepsy syndrome	6.63e-05	0.000358	CcSEcCtD
Candesartan—Dizziness—Pregabalin—epilepsy syndrome	6.59e-05	0.000356	CcSEcCtD
Candesartan—Asthenia—Gabapentin—epilepsy syndrome	6.56e-05	0.000354	CcSEcCtD
Candesartan—Nausea—Valproic Acid—epilepsy syndrome	6.55e-05	0.000354	CcSEcCtD
Candesartan—Pruritus—Gabapentin—epilepsy syndrome	6.47e-05	0.000349	CcSEcCtD
Candesartan—Vomiting—Pregabalin—epilepsy syndrome	6.34e-05	0.000342	CcSEcCtD
Candesartan—Gastrointestinal pain—Topiramate—epilepsy syndrome	6.29e-05	0.00034	CcSEcCtD
Candesartan—Rash—Pregabalin—epilepsy syndrome	6.28e-05	0.000339	CcSEcCtD
Candesartan—Dermatitis—Pregabalin—epilepsy syndrome	6.28e-05	0.000339	CcSEcCtD
Candesartan—Diarrhoea—Gabapentin—epilepsy syndrome	6.25e-05	0.000338	CcSEcCtD
Candesartan—Headache—Pregabalin—epilepsy syndrome	6.24e-05	0.000337	CcSEcCtD
Candesartan—Urticaria—Topiramate—epilepsy syndrome	6.11e-05	0.00033	CcSEcCtD
Candesartan—Abdominal pain—Topiramate—epilepsy syndrome	6.08e-05	0.000328	CcSEcCtD
Candesartan—Body temperature increased—Topiramate—epilepsy syndrome	6.08e-05	0.000328	CcSEcCtD
Candesartan—Dizziness—Gabapentin—epilepsy syndrome	6.04e-05	0.000326	CcSEcCtD
Candesartan—Nausea—Pregabalin—epilepsy syndrome	5.92e-05	0.00032	CcSEcCtD
Candesartan—Vomiting—Gabapentin—epilepsy syndrome	5.81e-05	0.000314	CcSEcCtD
Candesartan—Rash—Gabapentin—epilepsy syndrome	5.76e-05	0.000311	CcSEcCtD
Candesartan—Dermatitis—Gabapentin—epilepsy syndrome	5.76e-05	0.000311	CcSEcCtD
Candesartan—Headache—Gabapentin—epilepsy syndrome	5.73e-05	0.000309	CcSEcCtD
Candesartan—Asthenia—Topiramate—epilepsy syndrome	5.52e-05	0.000298	CcSEcCtD
Candesartan—Pruritus—Topiramate—epilepsy syndrome	5.44e-05	0.000294	CcSEcCtD
Candesartan—Nausea—Gabapentin—epilepsy syndrome	5.43e-05	0.000293	CcSEcCtD
Candesartan—Diarrhoea—Topiramate—epilepsy syndrome	5.26e-05	0.000284	CcSEcCtD
Candesartan—Dizziness—Topiramate—epilepsy syndrome	5.08e-05	0.000275	CcSEcCtD
Candesartan—Vomiting—Topiramate—epilepsy syndrome	4.89e-05	0.000264	CcSEcCtD
Candesartan—Rash—Topiramate—epilepsy syndrome	4.85e-05	0.000262	CcSEcCtD
Candesartan—Dermatitis—Topiramate—epilepsy syndrome	4.84e-05	0.000262	CcSEcCtD
Candesartan—Headache—Topiramate—epilepsy syndrome	4.82e-05	0.00026	CcSEcCtD
Candesartan—Nausea—Topiramate—epilepsy syndrome	4.57e-05	0.000247	CcSEcCtD
Candesartan—AGTR1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.74e-05	0.000235	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—COX3—epilepsy syndrome	1.73e-05	0.000234	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PLAT—epilepsy syndrome	1.73e-05	0.000234	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NEU1—epilepsy syndrome	1.72e-05	0.000233	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ATIC—epilepsy syndrome	1.72e-05	0.000233	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—UPB1—epilepsy syndrome	1.72e-05	0.000233	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.72e-05	0.000232	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.72e-05	0.000232	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.72e-05	0.000231	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.71e-05	0.000231	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.7e-05	0.000229	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.67e-05	0.000225	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.67e-05	0.000225	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—POMC—epilepsy syndrome	1.67e-05	0.000225	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.66e-05	0.000224	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	1.66e-05	0.000224	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.66e-05	0.000223	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.65e-05	0.000223	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.64e-05	0.000222	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.64e-05	0.000222	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.64e-05	0.000222	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.64e-05	0.000222	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.64e-05	0.000222	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JUNB—epilepsy syndrome	1.64e-05	0.000221	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CNR1—epilepsy syndrome	1.64e-05	0.000221	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.63e-05	0.00022	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.62e-05	0.000218	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	1.6e-05	0.000216	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GBE1—epilepsy syndrome	1.6e-05	0.000216	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HTR7—epilepsy syndrome	1.6e-05	0.000216	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CHRM3—epilepsy syndrome	1.6e-05	0.000216	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	1.6e-05	0.000216	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.58e-05	0.000214	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.57e-05	0.000211	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.57e-05	0.000211	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HBEGF—epilepsy syndrome	1.55e-05	0.00021	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.53e-05	0.000207	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.53e-05	0.000207	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.53e-05	0.000207	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.53e-05	0.000207	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.53e-05	0.000207	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.53e-05	0.000206	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT3—epilepsy syndrome	1.53e-05	0.000206	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—POMC—epilepsy syndrome	1.52e-05	0.000204	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	1.51e-05	0.000203	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—HMOX1—epilepsy syndrome	1.51e-05	0.000203	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.5e-05	0.000203	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.5e-05	0.000203	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.5e-05	0.000203	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.5e-05	0.000202	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.49e-05	0.000201	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.49e-05	0.000201	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ADAM10—epilepsy syndrome	1.49e-05	0.000201	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.49e-05	0.000201	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CAT—epilepsy syndrome	1.49e-05	0.0002	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL2—epilepsy syndrome	1.48e-05	0.0002	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	1.47e-05	0.000198	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.46e-05	0.000197	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.45e-05	0.000195	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ABCB1—epilepsy syndrome	1.44e-05	0.000195	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NT5E—epilepsy syndrome	1.43e-05	0.000193	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALAD—epilepsy syndrome	1.43e-05	0.000193	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.42e-05	0.000191	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—S100B—epilepsy syndrome	1.41e-05	0.00019	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.4e-05	0.000189	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.4e-05	0.000189	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.4e-05	0.000189	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.4e-05	0.000188	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.4e-05	0.000188	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SOCS3—epilepsy syndrome	1.39e-05	0.000188	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDC42—epilepsy syndrome	1.39e-05	0.000188	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	1.36e-05	0.000184	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	1.36e-05	0.000184	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.35e-05	0.000182	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.35e-05	0.000182	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AVP—epilepsy syndrome	1.35e-05	0.000182	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GPX1—epilepsy syndrome	1.34e-05	0.000181	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	1.33e-05	0.00018	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.31e-05	0.000177	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ADSL—epilepsy syndrome	1.31e-05	0.000176	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.3e-05	0.000176	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.3e-05	0.000176	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCG2—epilepsy syndrome	1.3e-05	0.000176	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.3e-05	0.000175	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GLUL—epilepsy syndrome	1.28e-05	0.000173	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.28e-05	0.000172	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.28e-05	0.000172	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HES1—epilepsy syndrome	1.27e-05	0.000172	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	1.27e-05	0.000171	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	1.26e-05	0.00017	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	1.26e-05	0.00017	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.25e-05	0.000169	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.25e-05	0.000169	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.25e-05	0.000168	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.25e-05	0.000168	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FYN—epilepsy syndrome	1.24e-05	0.000167	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.24e-05	0.000167	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—H2AFX—epilepsy syndrome	1.23e-05	0.000166	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MEF2C—epilepsy syndrome	1.23e-05	0.000166	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.23e-05	0.000165	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.22e-05	0.000164	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.19e-05	0.000161	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.19e-05	0.000161	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.19e-05	0.00016	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.19e-05	0.00016	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AGT—epilepsy syndrome	1.18e-05	0.000159	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NGF—epilepsy syndrome	1.18e-05	0.000159	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	1.18e-05	0.000159	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.16e-05	0.000157	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.16e-05	0.000157	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.16e-05	0.000157	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOE—epilepsy syndrome	1.15e-05	0.000156	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCR5—epilepsy syndrome	1.15e-05	0.000154	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.14e-05	0.000154	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AQP1—epilepsy syndrome	1.14e-05	0.000154	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	1.14e-05	0.000154	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.14e-05	0.000154	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.12e-05	0.000151	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.12e-05	0.000151	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.11e-05	0.00015	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.11e-05	0.00015	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.1e-05	0.000148	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.1e-05	0.000148	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.09e-05	0.000147	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.09e-05	0.000146	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	1.09e-05	0.000146	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—BCHE—epilepsy syndrome	1.08e-05	0.000146	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TSC2—epilepsy syndrome	1.06e-05	0.000144	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.06e-05	0.000143	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AGT—epilepsy syndrome	1.06e-05	0.000143	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.06e-05	0.000143	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.04e-05	0.000141	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOE—epilepsy syndrome	1.04e-05	0.000141	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	1.03e-05	0.000139	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	1.03e-05	0.000139	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	1.03e-05	0.000139	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.03e-05	0.000138	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	1.02e-05	0.000138	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KDR—epilepsy syndrome	1.02e-05	0.000138	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PLCB1—epilepsy syndrome	1.02e-05	0.000137	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.02e-05	0.000137	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TH—epilepsy syndrome	1.02e-05	0.000137	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.01e-05	0.000136	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1e-05	0.000135	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AQP1—epilepsy syndrome	9.95e-06	0.000134	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—POMC—epilepsy syndrome	9.91e-06	0.000134	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PRKCB—epilepsy syndrome	9.83e-06	0.000133	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6ST—epilepsy syndrome	9.79e-06	0.000132	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.62e-06	0.00013	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	9.58e-06	0.000129	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.43e-06	0.000127	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AQP1—epilepsy syndrome	9.3e-06	0.000125	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	9.1e-06	0.000123	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—epilepsy syndrome	9.04e-06	0.000122	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CHRM3—epilepsy syndrome	9e-06	0.000121	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	9e-06	0.000121	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—POMC—epilepsy syndrome	8.95e-06	0.000121	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.93e-06	0.00012	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL2—epilepsy syndrome	8.76e-06	0.000118	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMOX1—epilepsy syndrome	8.48e-06	0.000114	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	8.42e-06	0.000114	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	8.41e-06	0.000113	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	8.41e-06	0.000113	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CAT—epilepsy syndrome	8.37e-06	0.000113	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	8.21e-06	0.000111	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	8.16e-06	0.00011	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCB1—epilepsy syndrome	8.14e-06	0.00011	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.1e-06	0.000109	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGF2—epilepsy syndrome	7.92e-06	0.000107	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—epilepsy syndrome	7.91e-06	0.000107	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.83e-06	0.000106	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.67e-06	0.000103	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPX1—epilepsy syndrome	7.57e-06	0.000102	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.38e-06	9.96e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	7.36e-06	9.93e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RELA—epilepsy syndrome	7.35e-06	9.91e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCG2—epilepsy syndrome	7.34e-06	9.9e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MTOR—epilepsy syndrome	7.21e-06	9.72e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	7.15e-06	9.64e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	7.11e-06	9.58e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	7.01e-06	9.45e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—BCHE—epilepsy syndrome	6.98e-06	9.41e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	6.86e-06	9.24e-05	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	6.77e-06	9.13e-05	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.69e-06	9.02e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	6.68e-06	9.01e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	6.66e-06	8.98e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	6.64e-06	8.95e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AGT—epilepsy syndrome	6.63e-06	8.95e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CASP3—epilepsy syndrome	6.63e-06	8.94e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.59e-06	8.89e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	6.59e-06	8.88e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TH—epilepsy syndrome	6.56e-06	8.85e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—epilepsy syndrome	6.5e-06	8.77e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.46e-06	8.71e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JUN—epilepsy syndrome	6.44e-06	8.68e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	6.41e-06	8.65e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—epilepsy syndrome	6.26e-06	8.45e-05	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.12e-06	8.25e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	6.11e-06	8.23e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—BCHE—epilepsy syndrome	6.08e-06	8.2e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—epilepsy syndrome	6.08e-06	8.19e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	6.01e-06	8.1e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	5.99e-06	8.08e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	5.8e-06	7.82e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SRC—epilepsy syndrome	5.78e-06	7.79e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLCB1—epilepsy syndrome	5.74e-06	7.74e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TH—epilepsy syndrome	5.72e-06	7.71e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	5.7e-06	7.69e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—BCHE—epilepsy syndrome	5.68e-06	7.66e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—epilepsy syndrome	5.62e-06	7.59e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—POMC—epilepsy syndrome	5.58e-06	7.53e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	5.48e-06	7.39e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	5.42e-06	7.31e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CAT—epilepsy syndrome	5.4e-06	7.29e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	5.36e-06	7.23e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TH—epilepsy syndrome	5.34e-06	7.2e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.26e-06	7.09e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	5.26e-06	7.09e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—epilepsy syndrome	5.09e-06	6.87e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPX1—epilepsy syndrome	4.89e-06	6.59e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.77e-06	6.43e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CAT—epilepsy syndrome	4.71e-06	6.35e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	4.46e-06	6.01e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—epilepsy syndrome	4.45e-06	6.01e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CAT—epilepsy syndrome	4.4e-06	5.93e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AGT—epilepsy syndrome	4.29e-06	5.78e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	4.28e-06	5.77e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.26e-06	5.74e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—epilepsy syndrome	4.2e-06	5.66e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.98e-06	5.36e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—epilepsy syndrome	3.97e-06	5.36e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AGT—epilepsy syndrome	3.73e-06	5.03e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—epilepsy syndrome	3.66e-06	4.93e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—POMC—epilepsy syndrome	3.61e-06	4.86e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—epilepsy syndrome	3.59e-06	4.84e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.49e-06	4.7e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.42e-06	4.61e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—epilepsy syndrome	3.29e-06	4.43e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—POMC—epilepsy syndrome	3.14e-06	4.24e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.94e-06	3.96e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.88e-06	3.88e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—epilepsy syndrome	2.86e-06	3.86e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.68e-06	3.61e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.51e-06	3.38e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.34e-06	3.16e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.24e-06	3.02e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.45e-06	1.95e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.26e-06	1.7e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.18e-06	1.59e-05	CbGpPWpGaD
